470 related articles for article (PubMed ID: 24703352)
1. Long-term management of gout: nonpharmacologic and pharmacologic therapies.
Chaichian Y; Chohan S; Becker MA
Rheum Dis Clin North Am; 2014 May; 40(2):357-74. PubMed ID: 24703352
[TBL] [Abstract][Full Text] [Related]
2. [Gout: an overview of available urate lowering therapies].
Richette P
Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
[TBL] [Abstract][Full Text] [Related]
3. Update on emerging urate-lowering therapies.
Chohan S; Becker MA
Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
[TBL] [Abstract][Full Text] [Related]
4. Advances in pharmacotherapy for the treatment of gout.
Robinson PC; Dalbeth N
Expert Opin Pharmacother; 2015 Mar; 16(4):533-46. PubMed ID: 25547991
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and treatment of gout as a chronic disease.
Perez-Ruiz F; Herrero-Beites AM
Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis.
Zhang T; Pope JE
Rheumatology (Oxford); 2017 Jul; 56(7):1144-1153. PubMed ID: 28379501
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches to chronic hyperuricemia and gout.
Grassi D; Pontremoli R; Bocale R; Ferri C; Desideri G
High Blood Press Cardiovasc Prev; 2014 Dec; 21(4):243-50. PubMed ID: 24696068
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update.
Cicero AFG; Fogacci F; Kuwabara M; Borghi C
Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435164
[TBL] [Abstract][Full Text] [Related]
9. Major unanswered questions in the clinical gout field.
Stamp LK
Curr Opin Rheumatol; 2017 Mar; 29(2):171-177. PubMed ID: 27926541
[TBL] [Abstract][Full Text] [Related]
10. Pegloticase for treating refractory chronic gout.
George RL; Sundy JS
Drugs Today (Barc); 2012 Jul; 48(7):441-9. PubMed ID: 22844655
[TBL] [Abstract][Full Text] [Related]
11. Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients.
Chung TT; Yu KH; Kuo CF; Luo SF; Chiou MJ; Lan WC; Chen JS; Tseng WY; Hsieh AH; Wang LC
Arthritis Res Ther; 2019 Sep; 21(1):210. PubMed ID: 31533805
[TBL] [Abstract][Full Text] [Related]
12. Uricosuric medications for chronic gout.
Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
Fujimori S
Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and Clinical Management of Gouty Arthritis.
Saigal R; Agrawal A
J Assoc Physicians India; 2015 Dec; 63(12):56-63. PubMed ID: 27666904
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study.
Chou HW; Chiu HT; Tsai CW; Ting IW; Yeh HC; Huang HC; Kuo CC;
Nephrol Dial Transplant; 2018 Sep; 33(9):1620-1627. PubMed ID: 29165620
[TBL] [Abstract][Full Text] [Related]
16. New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond.
Schlesinger N
Curr Rheumatol Rep; 2010 Apr; 12(2):130-4. PubMed ID: 20425022
[TBL] [Abstract][Full Text] [Related]
17. [Recent advances in gout: pathogenesis, diagnosis, comorbidities, treatment].
Soós B; Szamosi S; Benkő S; Paragh G; Szekanecz Z
Orv Hetil; 2018 Oct; 159(40):1625-1636. PubMed ID: 30277413
[TBL] [Abstract][Full Text] [Related]
18. Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviews.
Kydd AS; Seth R; Buchbinder R; Falzon L; Edwards CJ; van der Heijde DM; Bombardier C
J Rheumatol Suppl; 2014 Sep; 92():33-41. PubMed ID: 25180126
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
[TBL] [Abstract][Full Text] [Related]
20. Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits.
Ellmann H; Bayat S; Araujo E; Manger B; Kleyer A; Cavallaro A; Lell M; Schenker H; Simon D; Tascilar K; Baraf HSB; Schett G; Rech J
Arthritis Rheumatol; 2020 Jan; 72(1):150-156. PubMed ID: 31353871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
